rpoB gene mutations among Mycobacterium tuberculosis isolates from extrapulmonary sites

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Azar Dokht KhosraviMehdi Mirsaeidi

Abstract

The aim of this study was to analyze mutations occurring in the rpoB gene of Mycobacterium tuberculosis (MTB) isolates from clinical samples of extrapulmonary tuberculosis (EPTB). Seventy formalin-fixed, paraffin-embedded samples and fresh tissue samples from confirmed EPTB cases were analyzed. Nested PCR based on the rpoB gene was performed on the extracted DNAs, combined with cloning and subsequent sequencing. Sixty-seven (95.7%) samples were positive for nester PCR. Sequence analysis of the 81 bp region of the rpoB gene demonstrated mutations in 41 (61.2%) of 67 sequenced samples. Several point mutations including deletion mutations at codons 510, 512, 513 and 515, with 45% and 51% of the mutations in codons 512 and 513 respectively were seen, along with 26% replacement mutations at codons 509, 513, 514, 518, 520, 524 and 531. The most common alteration was Gln → His, at codon 513, presented in 30 (75.6%) isolates. This study demonstrated sequence alterations in codon 513 of the 81 bp region of the rpoB gene as the most common mutation occurred in 75.6% of molecularly confirmed rifampin-resistant strains. In addition, simultaneous mutation at codons 512 and 513 was demonstrated in 34.3% of the isolates.

References

Jul 14, 1998·Antimicrobial Agents and Chemotherapy·D L WilliamsT P Gillis
Jul 8, 2005·Journal of Clinical Microbiology·Francesca MeacciMarco R Oggioni
Sep 7, 2007·The European Respiratory Journal·M ForssbohmH L Rieder
Jan 29, 2011·Journal of Clinical Microbiology·Doris HillemannElvira Richter
Nov 22, 2011·European Journal of Medicinal Chemistry·Ricardo FigueiredoMaria do Céu Costa
Aug 4, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Yun-Ho LinZhi-Yuan Shi
Aug 14, 2012·The American Journal of the Medical Sciences·Ameeta S KalokheMinh Ly T Nguyen
Oct 2, 2013·Indian Journal of Clinical Biochemistry : IJCB·Jemil S MakadiaAshwani Khanna
Aug 15, 2014·The Journal of Antibiotics·Beth P Goldstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.